Compile Data Set for Download or QSAR
Found 25 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 1500
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079375(CHEMBL3417008 | US9663465, 20)copy SMILEScopy InChI
Affinity DataKi:  0.900nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327460(4-amino-5-chloro-[[1-(cyclohexylmethyl)-4-piperidy...)copy SMILEScopy InChI
Affinity DataKi:  2.30nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327466(1-[4-amino-5-chloro-2-(2-fluoroéthoxy)phenyl]-3-[1...)copy SMILEScopy InChI
Affinity DataKi:  2.5nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327456(1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-[(piperi...)copy SMILEScopy InChI
Affinity DataKi:  2.5nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079365(CHEMBL3416996 | US9663465, 8)copy SMILEScopy InChI
Affinity DataKi:  3nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327448(1-(4-amino-5-fluoro-2-methoxyphenyl)-3-[1-(cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  3.80nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079366(CHEMBL3416997 | US9663465, 12)copy SMILEScopy InChI
Affinity DataKi:  3.90nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327461(4-amino-5-bromo-N-[[1-(cyclohexylmethyl)-4-piperid...)copy SMILEScopy InChI
Affinity DataKi:  5.40nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079362(CHEMBL3417009 | US9663465, 9)copy SMILEScopy InChI
Affinity DataKi:  7.10nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079369(CHEMBL3417000 | US9663465, 11)copy SMILEScopy InChI
Affinity DataKi:  8nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079368(CHEMBL3416999 | US9663465, 16)copy SMILEScopy InChI
Affinity DataKi:  8.20nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079364(CHEMBL3416995 | US9663465, 7)copy SMILEScopy InChI
Affinity DataKi:  8.80nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327445(1-(4-amino-5-bromo-2-methoxyphenyl)-3-[1-butyl-4-p...)copy SMILEScopy InChI
Affinity DataKi:  8.90nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327465(1-(4-amino-5-chloro-2-éthoxyphenyl)-3-[1-(cyclohex...)copy SMILEScopy InChI
Affinity DataKi:  12.5nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327467( 2-chloro-4-[[2-[1-(cyclohexylmethyl)-4-piperidyl]...)copy SMILEScopy InChI
Affinity DataKi:  13.1nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327462( 4-amino-5-iodo-N-[[1-(cyclohexylmethyl)-4-piperid...)copy SMILEScopy InChI
Affinity DataKi:  13.9nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50079363(CHEMBL3414597 | US9663465, 6)copy SMILEScopy InChI
Affinity DataKi:  14.8nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327457(1-(4-amino-5-bromo-2-methoxyphenyl)-3-[1-(cyclohex...)copy SMILEScopy InChI
Affinity DataKi:  17nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327458( 1-(4-amino-5-iodo-2-methoxyphenyl)-3-[1-(cyclohex...)copy SMILEScopy InChI
Affinity DataKi:  18.1nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM50122872(4-Amino-5-chloro-2,3-dihydro-benzofuran-7-carboxyl...)copy SMILEScopy InChI
Affinity DataKi:  44.1nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327446(1-(4-amino-5-iodo-2-methoxyphenyl)-3-[1-butyl-4-pi...)copy SMILEScopy InChI
Affinity DataKi:  44.7nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327444(1-(4-amino-2-methoxyphenyl)-3-[1-butyl-4-piperidyl...)copy SMILEScopy InChI
Affinity DataKi:  88.6nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327453(1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  125nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327447(1-(4-amino-2-methoxyphenyl)-3-[1-(cyclohexylmethyl...)copy SMILEScopy InChI
Affinity DataKi:  125nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
UNIVERSITE DE CAEN

US Patent
LigandPNGBDBM327464(1-(4-amino-5-chloro-2-hydroxyphenyl)-3-[1-(cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  125nMAssay Description:Prior to these competition studies, a series of saturation curves were performed in order to check whether the pharmacological parameters Kd, Bmax an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G2WUS Patent